2022 journal article

Stereotactic radiotherapy (10 Gy X 3) for canine nonlymphomatous intranasal tumors is associated with prolonged survival and minimal risk of severe radiotoxicity

JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 260(12), 1496–1506.

By: M. Nolan n, A. Berman n, M. Watson-Skaggs n, C. Quinn n, K. Marcus n, K. Russell n, H. Yoshikawa n, N. Olby n , T. Gieger n 

MeSH headings : Dogs; Animals; Retrospective Studies; Dog Diseases / surgery; Quality of Life; Radiosurgery / methods; Radiosurgery / veterinary; Chondrosarcoma / veterinary; Bone Neoplasms / veterinary; Death; Treatment Outcome
TL;DR: Oncologic outcomes following administration of a uniform stereotactic radiotherapy protocol for canine intranasal tumors are described and any clinical or dosimetric factors were predictive of event-free or overall survival time (EFST or OST) are identified. (via Semantic Scholar)
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: February 13, 2023

Abstract